Nutex Health Inc Stock Price, News & Analysis

Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro hospitals across 11 states, has scheduled its Q2 2025 financial results announcement. The company will release its second quarter results on Thursday, August 14, 2025 after market close, followed by a conference call on Friday, August 15, 2025 at 10:30 a.m. ET.

Investors can access the conference call via phone at 1-877-407-9208 or 1-201-493-6784, or through the participant link. A recording will be available on the company's website for those unable to attend the live call.

Nutex Health (NASDAQ: NUTX), a physician-led healthcare delivery system, has announced plans to ring the Nasdaq closing bell in New York City on August 26, 2025. The company will also host an investor meet and greet session in Midtown Manhattan from 9 AM to 1 PM EST on the same day.

Nutex Health operates 24 facilities across 11 states, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The company's structure consists of two main divisions: a Hospital Division and a Population Health Management Division, which manages provider networks such as Independent Physician Associations (IPAs).

Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro hospitals and HOPDs across 11 states, has issued a formal response to a recent short seller report. The company strongly refutes allegations regarding its collection process, stating that the report contains misrepresentations and demonstrates a misunderstanding of their business model.

Nutex Health emphasizes its robust internal process for coding, billing, and handling medical claims through independent dispute resolution when necessary. The company plans to provide additional updates in its upcoming Q2 2025 earnings release and Form 10-Q, expected by August 14, 2025.

Nutex Health (NASDAQ: NUTX), a physician-led healthcare system operating 24 micro hospitals and HOPDs across 11 states, has announced multiple community awards received during Q2 2025. The company's facilities earned recognition in various categories, including Best Emergency Care and Top Doc Awards.

Notable achievements include awards for The Colony ER Hospital, Wylie ER, Milwaukee ER & Hospital, Tucson ER & Hospital, and Texarkana Emergency Center & Hospital. Additionally, CEO Dr. Tom Vo was named a "Most Admired CEO Honoree" by the Houston Business Journal. These community-voted accolades reflect the company's commitment to patient-centric healthcare delivery.

Nutex Health (NASDAQ: NUTX), a physician-led healthcare delivery system with 24 micro hospitals and HOPDs across 11 states, has announced the filing of a supplement to its June 2, 2025 proxy statement. The company's Annual Meeting of common stockholders is scheduled for July 14, 2025 at 10:00 am Central Time.

Shareholders can access the proxy statement and Form 10-K online or request free paper/email copies through ProxyVote.com, by phone, or email with their control number.

Nutex Health Inc. (NASDAQ: NUTX), a physician-led healthcare delivery system, has been added to both the Russell 3000® Index and Russell Microcap® Index, effective June 30, 2025. This inclusion is part of the 2025 Russell indexes reconstitution, which captures the 4,000 largest U.S. stocks by market capitalization.

The company operates 24 micro hospitals and hospital outpatient departments across 11 states. Membership in these indexes, which remains in place for one year, provides automatic inclusion in other Russell indexes and their corresponding growth and value style indexes. Notably, approximately $10.6 trillion in assets are benchmarked against Russell US indexes as of June 2024.

Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 24 micro hospitals and HOPDs across 11 states, has announced the internet availability of proxy materials for its 2025 Annual Meeting. The virtual meeting will be held on July 14, 2025, at 10:00 am Central Time via www.virtualshareholdermeeting.com/NUTX2025. The company is utilizing the 'notice only' option for proxy material delivery, mailing notices to stockholders starting June 2, 2025. Shareholders can access materials online or request paper/email copies through ProxyVote.com, by calling 1-800-579-1639, or emailing sendmaterial@proxyvote.com. This administrative announcement details the process for accessing annual meeting materials and voting procedures.

Nutex Health (NASDAQ: NUTX) reported strong Q1 2025 financial results, with total revenue surging 213.8% to $211.8 million compared to $67.5 million in Q1 2024. The company achieved net income of $14.6 million versus a net loss of $0.4 million in Q1 2024, resulting in diluted EPS of $2.56. EBITDA increased by 507% to $43.1 million, while Adjusted EBITDA reached $72.8 million. The company's success was largely driven by arbitration efforts through the Independent Dispute Resolution process, contributing $105 million in additional revenue. Hospital division visits increased by 20.5% to 48,269, and the company maintained a strong financial position with $87.7 million in cash and cash equivalents. Notable achievements include record-high gross profit of 56% and $51.0 million in net cash from operating activities.

Nutex Health (NASDAQ: NUTX), a physician-led healthcare delivery system operating 24 micro hospitals across 11 states, has announced its schedule for the release of Q1 2025 financial results. The company will release its financial results for the quarter ended March 31, 2025, after market close on Tuesday, May 13, 2025.

A conference call to discuss the results is scheduled for Wednesday, May 14, 2025, at 10:30 a.m. ET. Participants can join via phone (1-877-407-9208 or 1-201-493-6784) or through a dedicated online link. For those unable to attend live, a recording will be available on the company's website.